Timur S. Syunyakov

Zakhidova G.A., Pikirenya V.I., Syunyakov T.S., Prilutskaya M.V.

Motives for new psychoactive substances consumption among young adults in Uzbekistan: a qualitative study protocol

Consortium Psychiatricum (2025. Vol. 6, no. 1, pp. 37–46)

DOI

10.17816/CP15531

22

Karpenko O.A., Syunyakov T.S., Kulygina M.A., Pavlichenko A.V., Chetkina A.S., Andryuschenko A.V.

Impact of COVID-19 Pandemic on Anxiety, Depression and Distress – Online Survey Results Amid the Pandemic in Russia

Consortium Psychiatricum (2020. Vol. 1, no. 1, pp. 8–20)

113

Kulygina M.A., Syunyakov T.S., Fedotov I.A., Kostyuk G.P.

Toward ICD-11 Implementation: Attitudes and Expectations of the Russian Psychiatric Community

Consortium Psychiatricum (2021. Vol. 2, no. 2, pp. 23–34)

DOI

10.17816/CP80

35

Zorkina Ya.A., Syunyakov T.S., Abramova O.V., Yunes R.A., Pavlichenko A.V., Pavlov K.A., Khobta E.B., Susloparova D.A., Tsarapkin G.Yu., Andreyuk D.S., Danilenko V.N., Gurina O.D., Morozova A.Yu.

Plasma Levels of Neurotrophic Factors are not Associated with the Severity of Depression

Consortium Psychiatricum (2021. Vol. 2, no. 4, pp. 13–22)

DOI

10.17816/CP110

45

Syunyakov T.S., Sharaev M.G., Savilov V.B., Karpenko O.A., Kurmyshev M.V., Yarkin V.E., Ushakov V.L., Bibyaev A.N., Soloveva K.P., Andryuschenko A.V.

A Comparison of Regional Brain Volumes in Older Adults With and Without History of COVID-19

Consortium Psychiatricum (2022. Vol. 3, no. 1, pp. 76–87)

DOI

10.17816/CP145

37

Syunyakov T.S., Pavlichenko A.V., Morozov P.V., Fedotov I.A., Filatova V.E., Gayduk A.J., Ignatenko J.S., Spikina A.A., Yashikhina A.A., Patsali M.E., Fountoulakis K.N., Smirnova D.A.

Modeling Suicidality Risks and Understanding the Phenomenon of Suicidality Under the Loupe of Pandemic Context: National Findings of the COMET-G Study in the Russian Population

Consortium Psychiatricum (2022. Vol. 3, no. 2, pp. 15–36)

DOI

10.17816/CP167

82

Reznik A.M., Syunyakov T.S., Arbuzov A.L.

Alcohol Addiction in War Veterans Treated in a In-patient Psychiatric Facility: Incidence, Comorbidity with PTSD Symptoms, Association with Combat Stressors

Consortium Psychiatricum (2022. Vol. 3, no. 3, pp. 73–89)

DOI

10.17816/CP188

86

Reznik A.M., Syunyakov T.S., Akhmerova I.Yu., Butylin D.Yu., Vasilenko A.O., Gvozdetckii A.N., Gizatullin T.R., Gilmanshina G.V., Golosov E.A., Kolchev S.A., Linova L.P., Miron D.V., Mudrak A.V., Oleichik I.V., Sizov S.V., Tarakanova E.A., Chesnokova O.I.

Clinical Effectiveness of Lurasidone Monotherapy in Patients with Acute Episodes of Schizophrenia and Associated Symptoms of Depression

Consortium Psychiatricum (2022. Vol. 3, no. 3, pp. 58–72)

DOI

10.17816/CP172

140

Reznik A.M., Syunyakov T.S., Mudrak A.V., Zakharov N.B., Popova Zh.B., Khoroshilova A.N., Khurbatova I.G., Sayfulina A.M., Eliseenko A.M., Matvievskaya T.K., Khannanova A.N.

Treatment of Depression with Vortioxetine and Second Generation Antipsychotics During the Period of Remission Formation in Schizophrenia (Interim Data Analysis)

Consortium Psychiatricum (2023. Vol. 4, no. 1, pp. 18–36)

DOI

10.17816/CP3728

45